BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22110194)

  • 21. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
    Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells.
    Rahman KM; Aranha O; Sarkar FH
    Nutr Cancer; 2003; 45(1):101-12. PubMed ID: 12791510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells.
    Abdelbaqi K; Lack N; Guns ET; Kotha L; Safe S; Sanderson JT
    Prostate; 2011 Sep; 71(13):1401-12. PubMed ID: 21321979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indole-3-carbinol induces tumor cell death: function follows form.
    Megna BW; Carney PR; Nukaya M; Geiger P; Kennedy GD
    J Surg Res; 2016 Jul; 204(1):47-54. PubMed ID: 27451867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells.
    Chatterji U; Riby JE; Taniguchi T; Bjeldanes EL; Bjeldanes LF; Firestone GL
    Carcinogenesis; 2004 Jul; 25(7):1119-28. PubMed ID: 14988219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
    Gao XD; Chen YR
    Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors.
    Chen SM; Tao ZZ; Hua QQ; Liu D; Chi HM; Cai Q
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):200-5. PubMed ID: 16490880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
    Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
    Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
    Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.
    Garikapaty VP; Ashok BT; Chen YG; Mittelman A; Iatropoulos M; Tiwari RK
    Oncol Rep; 2005 Jan; 13(1):89-93. PubMed ID: 15583807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN
    Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor alpha as a target for indole-3-carbinol.
    Wang TT; Milner MJ; Milner JA; Kim YS
    J Nutr Biochem; 2006 Oct; 17(10):659-64. PubMed ID: 16488130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of MUC1 expression by indole-3-carbinol.
    Lee IJ; Han F; Baek J; Hisatsune A; Kim KC
    Int J Cancer; 2004 May; 109(6):810-6. PubMed ID: 15027113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.